ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape

ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape

Leukemias derived from the MLL-AF9 rearrangement rely on dysfunctional transcriptional networks. ZNF521, a transcription co-factor implicated in the control of hematopoiesis, has been proposed to sustain leukemic transformation in collaboration with other oncogenes. Here, we demonstrate that ZNF521...

Full description

Bibliographic Details
Main Authors:	Emanuela Chiarella, Annamaria Aloisio, Stefania Scicchitano, Katia Todoerti, Emanuela G. Cosentino, Daniela Lico, Antonino Neri, Nicola Amodio, Heather Mandy Bond, Maria Mesuraca
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	International Journal of Molecular Sciences
Subjects:	acute myeloid leukemia (AML) cord blood-derived hematopoietic stem cells (CB-CD34<sup>+</sup>) human zinc finger protein 521 (hZNF521) mixed lineage leukemia gene (MLL) AF9 (MLLT3 or LTG9) fusion gene MLL-AF9 chromosomal translocations
Online Access:	https://www.mdpi.com/1422-0067/22/19/10814

Similar Items

Aggressive leukemia driven by MLL-AF9
by: Vaia Stavropoulou, et al.
Published: (2018-05-01)

High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in <i>MLL/AF9</i> Acute Myeloid Leukemia
by: Longlong Liu, et al.
Published: (2022-01-01)

Regulatory Role of microRNAs Targeting the Transcription Co-Factor ZNF521 in Normal Tissues and Cancers
by: Emanuela Chiarella, et al.
Published: (2021-08-01)

Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
by: Yanan Gao, et al.
Published: (2016-04-01)

circRNA circAF4 functions as an oncogene to regulate MLL-AF4 fusion protein expression and inhibit MLL leukemia progression
by: Wei Huang, et al.
Published: (2019-10-01)

HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis
by: Satoshi Takahashi, et al.
Published: (2021-08-01)

MLL-AF4 and a murinized pSer-variant thereof are turning on the nucleolar stress pathway
by: Anna Lena Siemund, et al.
Published: (2022-04-01)

MiRNA-495 regulates proliferation and apoptosis of acute myeloid leukemia cells with MLL gene rearrangement by targeting STYX
by: YANG Rui, et al.
Published: (2021-11-01)

Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates <i>HOXA9</i> Gene Expression in t(4;11) Leukemia Cells
by: Tiziana Fioretti, et al.
Published: (2021-04-01)

Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4–MLL Fusion Protein
by: Samaneh Sabiani, et al.
Published: (2015-05-01)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01)

Histone H3K36me2-Specific Methyltransferase ASH1L Promotes MLL-AF9-Induced Leukemogenesis
by: Mohammad B. Aljazi, et al.
Published: (2021-10-01)

Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation
by: Branco M. H. Heuts, et al.
Published: (2023-04-01)

Effect of Down-regulation of MLLT3/AF9 Expression on Proliferation and Invasion Abilities of Hepatoma SMMC-7721 Cells
by: FENG Pengcheng, et al.
Published: (2018-05-01)

Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma
by: Stefania Scicchitano, et al.
Published: (2023-09-01)

Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation
by: Cristiana Barone, et al.
Published: (2023-07-01)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
by: Farinoosh Dadrass, et al.
Published: (2022-08-01)

RNA binding proteins in MLL-rearranged leukemia
by: Tiffany M. Tran, et al.
Published: (2022-10-01)

CDK6 Inhibition: A Novel Approach in AML Management
by: Iris Z. Uras, et al.
Published: (2020-04-01)

<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
by: Oliver Britten, et al.
Published: (2019-10-01)

A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1
by: Masashi Numata, et al.
Published: (2023-02-01)

Genomic characterization of mixed lineage leukemias
by: S. Dogan
Published: (2020-03-01)

MAT2A as Key Regulator and Therapeutic Target in <i>MLL</i>r Leukemogenesis
by: Kathy-Ann Secker, et al.
Published: (2020-05-01)

Functional interrogation of HOXA9 regulome in MLLr leukemia via reporter-based CRISPR/Cas9 screen
by: Hao Zhang, et al.
Published: (2020-10-01)

ZNF521/EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells
by: Yu Cheng, et al.
Published: (2023-03-01)

Uncovering NOTCH1 as a Promising Target in the Treatment of <i>MLL</i>-Rearranged Leukemia
by: Jacqueline Fischer, et al.
Published: (2023-09-01)

Your dilemma, my identity: Unusual immunogenetic profiles of pediatric B cell acute lymphoblastic leukemia
by: Anurag Gupta, et al.
Published: (2014-01-01)

Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
by: Alexia Tsakaneli, et al.
Published: (2021-09-01)

Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
by: Kun-yin Qiu, et al.
Published: (2022-12-01)

Green Lynx Spider, Peucetia viridans (Hentz) (Arachnida: Araneae: Oxyopidae)
by: Howard V. Weems, Jr., et al.
Published: (2004-08-01)

Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia
by: Elizabeth Moschiano, et al.
Published: (2016-01-01)

SETD2 in MLL-rearranged leukemia – a complex case
by: Anna Skucha, et al.
Published: (2018-07-01)

Telomere Transcription in <i>MLL</i>-Rearranged Leukemia Cell Lines: Increased Levels of TERRA Associate with Lymphoid Lineage and Are Independent of Telomere Length and Ploidy
by: Corrado Caslini, et al.
Published: (2023-03-01)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
by: Thomas A. Milne, et al.
Published: (2012-09-01)

Pediatric M5 acute myeloid leukemia with MLL-SEPT6 fusion and a favorable outcome
by: Alain Chebly, et al.
Published: (2021-01-01)

Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance
by: Adel Abdelhaleim Hagag, et al.
Published: (2014-01-01)

Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
by: Rahel Fitzel, et al.
Published: (2023-07-01)

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
by: Alvaro Muñoz-López, et al.
Published: (2016-10-01)

RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation
by: Akihiko Yokoyama
Published: (2019-01-01)

Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the Republic of Belarus
by: Yu. A. Barovskaya, et al.
Published: (2019-01-01)